CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,072,960
- in 74 filings, $341.3M under 10b5-1 plans
Net −$342,072,960. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,320 | $551.35 | $728K | 43,493 |
| 2026-06-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,760 | $552.45 | $1.5M | 40,733 |
| 2026-06-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −220 | $552.89 | $122K | 40,513 |
| 2026-06-09 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 69,410 | ||
| 2026-06-08 | EDGEMOND JAMES CFO AND TREASURER | Option exercise 10b5-1 | +10,000 | $117.76 | $1.2M | 28,876 |
| 2026-06-08 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,565 | $544.93 | $853K | 27,311 |
| 2026-06-08 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,989 | $546.13 | $1.1M | 25,322 |
| 2026-06-08 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,888 | $547.03 | $1.0M | 23,434 |
| 2026-06-08 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −2,158 | $547.91 | $1.2M | 21,276 |
| 2026-06-08 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −425 | $549.38 | $233K | 20,851 |
| 2026-06-08 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,285 | $550.09 | $707K | 19,566 |
| 2026-06-08 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −610 | $551.28 | $336K | 18,956 |
| 2026-06-08 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −80 | $551.76 | $44K | 18,876 |
| 2026-06-08 | EDGEMOND JAMES CFO AND TREASURER | Option exercise · Stock Option 10b5-1 | −10,000 | 20,000 | ||
| 2026-06-08 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 50,013 |
| 2026-06-08 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,462 | $544.89 | $797K | 48,551 |
| 2026-06-08 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,131 | $546.13 | $1.2M | 46,420 |
| 2026-06-08 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,525 | $547.07 | $834K | 44,895 |
| 2026-06-08 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,144 | $547.93 | $1.2M | 42,751 |
| 2026-06-08 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −948 | $549.58 | $521K | 41,803 |
Page 87 of 120 · 2,391 trades